Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Flushing | 1% - 29.2% | x | x | ||
Erythema | 0% - 0.6% | x | x | ||
Wheezing | 0% - 0.3% | x | x | ||
Pruritus | 0% - 0.4% | x | x | ||
Anaphylactic shock | postmarketing | x | |||
Edema cerebral | postmarketing | x | |||
Connective tissue disorder | postmarketing | x | |||
Immune system disorder | postmarketing | x | |||
Myopathy | postmarketing | x | |||
Nervous system disorder | postmarketing | x | |||
Convulsion | postmarketing | x | x | x | |
Uremia | postmarketing | x | |||
Urticaria | postmarketing, 0% - 0.2% | x | x | x | |
Trauma | postmarketing | x | |||
Muscular weakness | postmarketing | x | |||
Unspecified disorder of skin and subcutaneous tissue | postmarketing | x | |||
Encephalitis viral | postmarketing | x | |||
Anaphylactoid reaction | postmarketing | x | x | ||
Hypoxic-ischaemic encephalopathy | postmarketing | x | |||
Bronchospasm | x | x | |||
Dyspnoea | x | x | |||
Rash | x | x | |||
Cardiac arrest | x | x | |||
Hypersensitivity | x | x | |||
Hypotension | x | x | x | ||
Laryngospasm | x | x | |||
Mediastinal disorder | x | ||||
Tachycardia | x | x | |||
Angiopathy | x | ||||
Mean arterial pressure | x | x | |||
Bradycardia | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |